Company

IMMR
Deals-complete

December 2016

Deal completed

revenues

€14M+

Revenues

sector

Healthcare

Sector

01

Business

MedTech preclinical studies in large models

IMMR performs preclinical studies on large animals (mainly pigs and sheep) for large corporates and med-tech start-ups. The company operates on an international scale (>75% of foreign revenues in 2019). IMMR’s owns a worldwide recognition in cardiovascular research (ex: valves and stent). IMMR provides a full range of services fully compliant with the Good Laboratory Practice (GLP).

02

Strategy

Create an international leader in complex preclinical studies

IMMR will strengthen its leadership on the European market of complex preclinical studies on large models through the development of new services and the acceleration of its international expansion (mainly in USA). In the same time, IMMR will take care to maintain the highest professional standard of quality by keeping a high level of investment.

03

Others deals

Camusat

+ Read more

Les Zelles

+ Read more

Travelsoft

+ Read more